📊 RFL Key Takeaways
Is RFL a Good Investment? Thesis Analysis
Rafael Holdings is a pre-commercial pharmaceutical company with minimal revenue ($451K) against massive operating losses ($16.8M), resulting in unsustainable cash burn of $14.3M annually. Despite a strong balance sheet ($79.2M equity, $37.8M cash), the company will exhaust cash reserves within ~2.6 years without profitability inflection or additional financing, making fundamental financial health highly deteriorated.
Why Buy RFL? Key Strengths
- Strong liquidity position with 3.44x current ratio and $37.8M cash reserves
- Minimal debt burden (0.00x debt-to-equity) providing financial flexibility
- Explosive revenue growth of 2956.7% YoY suggests recent product commercialization or market entry
RFL Investment Risks to Consider
- Severe cash burn of $14.3M annually against only $451K revenue creates unsustainable financial model
- Operating losses of $16.8M represent 3724% of revenue, indicating inability to scale operations profitably
- Negative operating cash flow indicates core business is not self-sustaining; company will require dilutive financing within 2-3 years
Key Metrics to Watch
- Quarterly revenue progression and pipeline advancement toward profitability
- Monthly cash burn rate and runway remaining before financing need
- Gross margin achievement as revenue scales and manufacturing efficiency improves
RFL Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 3.44x current ratio provides a solid financial cushion.
RFL Profitability Ratios
RFL vs Healthcare Sector
How Rafael Holdings, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is RFL Overvalued or Undervalued?
Based on fundamental analysis, Rafael Holdings, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
RFL Balance Sheet & Liquidity
RFL 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Rafael Holdings, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-1.45 indicates the company is currently unprofitable.
RFL Growth Metrics (YoY)
RFL Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $77.0K | -$4.6M | $-0.13 |
| Q1 2026 | $128.0K | -$9.0M | $-0.19 |
| Q3 2025 | $336.0K | -$4.8M | $-0.19 |
| Q2 2025 | $68.0K | $2.4M | $0.10 |
| Q1 2025 | $68.0K | -$3.6M | $-0.15 |
| Q3 2024 | $71.0K | -$1.4M | $-0.06 |
| Q2 2024 | $68.0K | -$1.7M | $-0.08 |
| Q1 2024 | $68.0K | $1.6M | $0.07 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
RFL Capital Allocation
RFL SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Rafael Holdings, Inc. (CIK: 0001713863)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RFL
What is the AI rating for RFL?
Rafael Holdings, Inc. (RFL) has an AI rating of SELL with 72% confidence, based on fundamental analysis of SEC EDGAR filings.
What are RFL's key strengths?
Claude: Strong liquidity position with 3.44x current ratio and $37.8M cash reserves. Minimal debt burden (0.00x debt-to-equity) providing financial flexibility.
What are the risks of investing in RFL?
Claude: Severe cash burn of $14.3M annually against only $451K revenue creates unsustainable financial model. Operating losses of $16.8M represent 3724% of revenue, indicating inability to scale operations profitably.
What is RFL's revenue and growth?
Rafael Holdings, Inc. reported revenue of $451.0K.
Does RFL pay dividends?
Rafael Holdings, Inc. does not currently pay dividends.
Where can I find RFL SEC filings?
Official SEC filings for Rafael Holdings, Inc. (CIK: 0001713863) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RFL's EPS?
Rafael Holdings, Inc. has a diluted EPS of $-0.32.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RFL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Rafael Holdings, Inc. has a SELL rating with 72% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RFL stock overvalued or undervalued?
Valuation metrics for RFL: ROE of -20.5% (sector avg: 15%), net margin of -3,599.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RFL stock in 2026?
Our dual AI analysis gives Rafael Holdings, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RFL's free cash flow?
Rafael Holdings, Inc.'s operating cash flow is $-14.3M, with capital expenditures of $5.0K. FCF margin is -3,178.3%.
How does RFL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -3,599.3% (avg: 12%), ROE -20.5% (avg: 15%), current ratio 3.44 (avg: 2).